For Schering, which has been making strides into biotech and cancer treatment with a treatment for multiple sclerosis and Campath, a cancer drug licensed from Ilex Oncology (nasdaq: ILXO - news - people ), it is a strategic step forward.
FORBES: Schering AG Makes Biotech Strides